Kazia Therapeutics (KZIA) Total Liabilities (2017 - 2025)

Kazia Therapeutics (KZIA) has disclosed Total Liabilities for 6 consecutive years, with $5.3 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Total Liabilities fell 74.47% year-over-year to $5.3 million, compared with a TTM value of $5.3 million through Jun 2025, down 74.47%, and an annual FY2025 reading of $5.4 million, down 74.04% over the prior year.
  • Total Liabilities was $5.3 million for Q2 2025 at Kazia Therapeutics, down from $20.8 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $20.8 million in Q2 2024 and bottomed at $5.3 million in Q2 2025.
  • Average Total Liabilities over 4 years is $12.4 million, with a median of $11.7 million recorded in 2022.
  • The sharpest move saw Total Liabilities soared 94.34% in 2024, then crashed 74.47% in 2025.
  • Year by year, Total Liabilities stood at $12.6 million in 2022, then decreased by 15.06% to $10.7 million in 2023, then skyrocketed by 94.34% to $20.8 million in 2024, then plummeted by 74.47% to $5.3 million in 2025.
  • Business Quant data shows Total Liabilities for KZIA at $5.3 million in Q2 2025, $20.8 million in Q2 2024, and $10.7 million in Q2 2023.